Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
3 Medical Stocks to Consider as Markets Take a Breather
These top medical stocks may be able to provide defensive safety after President Trump's tariff hikes and July's unfavorable jobs report led to a market selloff.
CVS Targets Strong Weight-Loss Drug Use as Revenues Tick Up
CVS is focusing heavily on technology-led care after posting solid Q2 earnings. “We are building momentum as we navigate what continues to be a dynamic and evolving environment,” Chief Executive David Joyner told analysts on an earnings call Thursday (July 31), crediting the company's “diversified business” for offsetting swings in medical costs.
CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised
CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin gains.
CVS Health (CVS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally.
The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.
CVS Health Stock Soars on Strong Results, Raised 2025 Profit Outlook
Shares of CVS Health (CVS) jumped in premarket trading Thursday after the health care giant posted better-than-expected second-quarter results and lifted its full-year adjusted profit forecast.
CVS Health (CVS) Beats Q2 Earnings and Revenue Estimates
CVS Health (CVS) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.47 per share. This compares to earnings of $1.83 per share a year ago.
CVS beats estimates, hikes adjusted profit outlook on retail pharmacy and insurance unit strength
CVS Health reported second-quarter earnings and revenue that topped estimates and raised its adjusted profit outlook. CVS CEO David Joyner pointed to strength in its retail pharmacy business and some improvement in its insurance unit, Aetna, which is grappling with higher medical costs.
CVS Health reported earnings that beat Wall Street's expectations and upgraded its projection for 2025, as its health-insurance business showed signs of recovery
The healthcare giant's results underscore a split among insurers between those that are struggling and those that are beginning to revive.
Is CVS Health (CVS) Stock Outpacing Its Medical Peers This Year?
Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.
CVS Health Care Delivery: Will the Growth Momentum Last in Q2?
CVS' Health Care Delivery unit posts strong growth from Signify and Oak Street, but rising medical costs pose a near-term risk.
